Deals & Capital Markets
BioMarin Bets $4.8 Billion on Amicus to Create Rare Disease Powerhouse
Dec 19, 2025
You're signed outSign in or to get full access.
BIOMARIN PHARMACEUTICAL (BMRN) Earnings Call Transcripts
Browse quarterly earnings call transcripts for BIOMARIN PHARMACEUTICAL.
Q4 2025
Feb 23, 2026
Q3 2025
Oct 27, 2025
Q2 2025
Aug 4, 2025
Q1 2025
May 1, 2025
Q4 2024
Feb 19, 2025
Q3 2024
Oct 29, 2024
Q2 2024
Aug 5, 2024
Q1 2024
Apr 24, 2024
Q4 2023
Feb 22, 2024
Q3 2023
Nov 1, 2023
Q2 2023
Jul 31, 2023